{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:50:40Z","timestamp":1754153440675,"version":"3.41.2"},"reference-count":50,"publisher":"Bentham Science Publishers Ltd.","issue":"5","funder":[{"DOI":"10.13039\/501100007409","name":"Doctoral Initiation Fund of Chengde Medical College","doi-asserted-by":"publisher","award":["202301"],"award-info":[{"award-number":["202301"]}],"id":[{"id":"10.13039\/501100007409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Hebei Natural Science Foundation","doi-asserted-by":"publisher","award":["H2023406003","H2023406037"],"award-info":[{"award-number":["H2023406003","H2023406037"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003482","name":"Innovation and Entrepreneurship Education Teaching Reform Research and Practice Project of Department of Education of Hebei Province","doi-asserted-by":"publisher","award":["2023cxcy147"],"award-info":[{"award-number":["2023cxcy147"]}],"id":[{"id":"10.13039\/501100003482","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Postdoctoral Fund of Shandong Daguan Pharmaceutical Technology Co., LTD","award":["SDDG20230101-1"],"award-info":[{"award-number":["SDDG20230101-1"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["COS"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Timolol maleate is clinically used for the treatment of hypertension, angina pectoris, tachycardia, and glaucoma.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The aim of this study was to enhance the safe use of timolol maleate and investigate a\nsynthesis method for 3-S-timolol, a newly identified impurity in timolol API (Active Pharmaceutical Ingredients).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>(S)-3-(tert-butylamino)propane-1,2-diol (1) was used as a raw material. 3-S-timolol\nmaleate (7) was synthesized through a five-step reaction. Overall yield was 57.7%, with a purity\nof 98%.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The structure of the target compound was confirmed via analysis of its 1H nuclear magnetic resonance, 13C nuclear magnetic resonance, and high-resolution mass spectrometry spectra.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The synthesis method was straightforward and yielded a high-purity product suitable\nfor use as a reference in the analysis and identification of timolol maleate-related substances.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115701794344307241027093947","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:44:51Z","timestamp":1738629891000},"page":"614-619","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synthesis and Characterization of 3-S-impurities in Timolol Maleate"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6432-1493","authenticated-orcid":true,"given":"Dejun","family":"Zhou","sequence":"first","affiliation":[{"name":"The key Laboratory of Chinese Medicine Research and Development in Hebei Province, Traditional Chinese Medicine\nInstitute of Chengde Medical University, Chengde, 067000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyang","family":"Wang","sequence":"additional","affiliation":[{"name":"Shandong Daguan Pharmaceutical Technology Co\nLtd, Jinan, Shandong, 250100, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuying","family":"Zhang","sequence":"additional","affiliation":[{"name":"The key Laboratory of Chinese Medicine Research and Development in Hebei Province, Traditional Chinese Medicine\nInstitute of Chengde Medical University, Chengde, 067000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyue","family":"Liu","sequence":"additional","affiliation":[{"name":"The key Laboratory of Chinese Medicine Research and Development in Hebei Province, Traditional Chinese Medicine\nInstitute of Chengde Medical University, Chengde, 067000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Mao","sequence":"additional","affiliation":[{"name":"The key Laboratory of Chinese Medicine Research and Development in Hebei Province, Traditional Chinese Medicine\nInstitute of Chengde Medical University, Chengde, 067000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijbiomac.2020.04.274","volume":"159","author":"Pakzad Y.","year":"2020","unstructured":"Pakzad Y.; Fathi M.; Omidi Y.; Mozafari M.; Zamanian A.; Synthesis and characterization of timolol maleate-loaded quaternized chitosan-based thermosensitive hydrogel: A transparent topical ocular delivery system for the treatment of glaucoma. Int J Biol Macromol  2020,159,117-128","journal-title":"Int J Biol Macromol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.3390\/ijms23169478","volume":"23","author":"Jun I.","year":"2022","unstructured":"Jun I.; Choi Y.J.; Kim B.R.; Seo K.Y.; Kim T.; Activation of ADRB2\/PKA signaling pathway facilitates lipid synthesis in meibocytes, and beta-blocker glaucoma drug impedes PKA-induced lipid synthesis by inhibiting ADRB2. Int J Mol Sci  2022,23(16),9478","journal-title":"Int J Mol Sci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e25815","DOI":"10.7759\/cureus.25815","volume":"14","author":"May G.","year":"2022","unstructured":"May G.; Miller D.; Fuchs D.; Bradycardia from a non-selective beta-adrenergic antagonist, timolol, applied ophthalmologically for glaucoma. Cureus  2022,14(6),e25815","journal-title":"Cureus"},{"key":"ref=4","first-page":"4","volume":"121","author":"Hagan J.C.","year":"2024","unstructured":"Hagan J.C.; III First world literature report: Attention pharma and headache researchers! Nasal spray timolol may be the next great thing for acute migraine. Mo Med  2024,121(1),4-5","journal-title":"Mo Med"},{"key":"ref=5","first-page":"33","volume":"121","author":"Kosa S.C.","year":"2024","unstructured":"Kosa S.C.; Hagan J.C.; III Nasally delivered 0.5% timolol beta blocker successfully treats acute migraines in a referral headache clinic: A case series. Mo Med  2024,121(1),33-36","journal-title":"Mo Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.14715\/cmb\/2023.69.10.16","volume":"69","author":"Hongjian Zhu","year":"2023","unstructured":"Hongjian Zhu ; Hua Luo ; Wenjuan Lai ; Efficacy of timolol in the treatment of facial hemangioma and its effect on the proliferation and apoptosis of hemangioma stem cells. Cell Mol Biol  2023,69(10),115-120","journal-title":"Cell Mol Biol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/SCS.0000000000010001","volume":"35","author":"Han K.","year":"2024","unstructured":"Han K.; Wei J.J.; Zheng H.; Li X.D.; Zhang A.X.; Ma Y.H.; Meng J.; Hu Y.Y.; Efficacy and safety of oral propranolol or topical timolol for the treatment of superficial infantile hemangiomas. Craniofacial surgery  2024,35,254-257","journal-title":"Craniofacial surgery"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ad.2021.09.014","volume":"114","author":"Lopez-Bernal T.","year":"2023","unstructured":"Lopez-Bernal T.; Aranegui B.; RF-FTopical Timolol in dermatology. Actas dermo-sifiliograficas  2023,114(4),334-335","journal-title":"Actas dermo-sifiliograficas"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jdcr.2023.07.002","volume":"39","author":"Toker M.","year":"2023","unstructured":"Toker M.; Antohi D.R.; Srivastava P.; Amin B.; Wu B.; COVID\u201319-associated diffuse dermal angiomatosis managed with pentoxifylline and topical timolol. JAAD Case Rep  2023,39,34-36","journal-title":"JAAD Case Rep"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jaapos.2017.10.015","volume":"22","author":"Gummi R.","year":"2018","unstructured":"Gummi R.; Stahl E.D.; Marsh J.D.; Topical timolol for an iris hemangioma. J AAPOS  2018,22(2),156-158","journal-title":"J AAPOS"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.16761\/j.cnki.1000-4963.2022.05.015","volume":"51","author":"Yin R.R.","year":"2022","unstructured":"Yin R.R.; Hao D.; Wu Q.; Wang J.; Wang B.H.; Chen P.; Feng Y.T.; Ji R.F.; Clinical observation of topical timolol maleate ophthalmic solution for the treatment of superficial infantile hemangiomas of the scalp. J Clin Dermatol  2022,51,299-302","journal-title":"J Clin Dermatol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.12669\/pjms.40.2(ICON).8983","volume":"40","author":"Mazhar A.","year":"2023","unstructured":"Mazhar A.; Ghouse A.N.; Mallick Y.A.; Samad L.; Efficacy of 0.5% timolol maleate gel in the management of infantile hemangiomas. Pak J Med Sci  2023,40(2(ICON))(Suppl.),S75-S79","journal-title":"Pak J Med Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/ced.15021","volume":"47","author":"Alzaid M.","year":"2022","unstructured":"Alzaid M.; Al-Naseem A.; Al-Niaimi F.; Ali F.R.; Topical timolol in dermatology: Infantile haemangiomas and beyond. Clin Exp Dermatol  2022,47(5),819-832","journal-title":"Clin Exp Dermatol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1080\/08164622.2021.1952843","volume":"105","author":"Agrawal S.","year":"2022","unstructured":"Agrawal S.; Modaboyina S.; Bajaj M.S.; Gupta S.; Das D.; Effectiveness of treatment of acquired capillary haemangioma using timolol. Clin Exp Optom  2022,105(5),556-557","journal-title":"Clin Exp Optom"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1055\/a-1645-1665","volume":"238","author":"Hildebrand G.D.","year":"2021","unstructured":"Hildebrand G.D.; Sipkova Z.; Topical Timolol for infantile haemangioma of the orbit. Klin Monatsbl Augenheilkd  2021,238(10),1069-1076","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/jamadermatol.2023.2765","volume":"159","author":"Hwang A.S.","year":"2023","unstructured":"Hwang A.S.; Hoss E.; Pittelkow M.R.; Yang Y.W.; Treatment of Hydroxyurea-induced ulcers with Timolol. JAMA Dermatol  2023,159(11),1277-1279","journal-title":"JAMA Dermatol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ophtha.2022.04.019","volume":"130","author":"Priluck A.","year":"2023","unstructured":"Priluck A.; Bacorn C.; Rajaii F.; Rapid involution of presumed pyogenic granuloma with topical Timolol. Ophthalmology  2023,130(1),27","journal-title":"Ophthalmology"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/ced\/llad296","volume":"49","author":"Brent G.","year":"2023","unstructured":"Brent G.; Al-Wahab Y.; Natkunarajah J.; Topical timolol 0.5% as a novel therapeutic approach for Hailey\u2013Hailey disease. Clin Exp Dermatol  2023,49(1),76-78","journal-title":"Clin Exp Dermatol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.jaad.2020.05.100","volume":"85","author":"Pawar M.K.","year":"2021","unstructured":"Pawar M.K.; Treatment of painful and deep fissures of the heel with topical timolol. J Am Acad Dermatol  2021,85(1),e3-e4","journal-title":"J Am Acad Dermatol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/ajd.12817","volume":"59","author":"Abdelmaksoud A.","year":"2018","unstructured":"Abdelmaksoud A.; Filoni A.; Giudice G.; Vestita M.; Topical timolol for Kaposi sarcoma: An innovation. Australas J Dermatol  2018,59(4),340-341","journal-title":"Australas J Dermatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1742-7843.2011.00694.x","volume":"108","author":"Volotinen M.","year":"2011","unstructured":"Volotinen M.; Hakkola J.; Pelkonen O.; Vapaatalo H.; M\u00e4enp\u00e4 J.; Metabolism of ophthalmic timolol: New aspects of an old drug. Basic Clin Pharmacol Toxicol  2011,108(5),297-303","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=22","first-page":"1080","volume":"2","year":"2016","unstructured":"British Pharmacopoeia The Stationery Officon behalf of the Medicines and Healthcare products Regulatory Agency (MHRA)  2016,2,1080-1082","journal-title":"The Stationery Officon behalf of the Medicines and Healthcare products Regulatory Agency (MHRA)"},{"key":"ref=23","first-page":"41","volume":"7","author":"Shui Q.H.","year":"2005","unstructured":"Shui Q.H.; Li Z.M.; Yu S.M.; Determination of the related substances in timolol maleate eye drops by HPLC. Food and Drug  2005,7,41-42","journal-title":"Food and Drug"},{"key":"ref=24","first-page":"1138","volume":"12","author":"Hu B.","year":"2012","unstructured":"Hu B.; Shan X.Y.; Determination of related substances in Timolol Maleate eye drops by HPLC. Chinese Pharmacists  2012,12,1138-1140","journal-title":"Chinese Pharmacists"},{"key":"ref=25","first-page":"2208","volume":"29","author":"Liu H.Y.","year":"2018","unstructured":"Liu H.Y.; Cheng Q.Z.; Zhou M.; Yi Q.; Determination of related substance and impurities qualitative study of Timolol Maleate eye drops. Chinese Pharmacy  2018,29,2208-2214","journal-title":"Chinese Pharmacy"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.16155\/j.0254-1793.2024.03.10","volume":"44","author":"Tian H.","year":"2024","unstructured":"Tian H.; Wu C.M.; Yan Q.H.; Identification and determination of related substances of timolol maleate. J Pharm Anal  2024,44,450-461","journal-title":"J Pharm Anal"},{"key":"ref=27","first-page":"1676","volume":"41","author":"Fei L.H.","year":"2022","unstructured":"Fei L.H.; Fei H.Y.; Wu J.; Determination of Timolol Maleate and related substances in Travoprost and Timolol Maleate eye drops by HPLC. Herald of Medicine  2022,41(11),1676-1680","journal-title":"Herald of Medicine"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.19526\/j.cnki.1005-8915.20210308","volume":"28","author":"Ji X.R.","year":"2021","unstructured":"Ji X.R.; Liu Y.Y.; Gao Z.; Kong Y.; Determination of related substances in Timolol Maleate by HPLC. Pharm Biotechnol  2021,28(3),261-265","journal-title":"Pharm Biotechnol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.16155\/j.0254-1793.2000.03.016","volume":"20","author":"Huo X.M.","year":"2000","unstructured":"Huo X.M.; Determination of related substances in Timolol Maleate and its eye drops by reversed phase Ion-pair HPLC. J Pharm Anal  2000,20(03),181-184","journal-title":"J Pharm Anal"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/chir.530060607","volume":"6","author":"Lacroix P.M.","year":"1994","unstructured":"Lacroix P.M.; Dawson B.A.; Sears R.W.; Black B.; HPLC and NMR methods for the quantitation of the (R)-enantiomer in (-)-(S)-timolol maleate drug raw materials. Chirality  1994,6(6),484-491","journal-title":"Chirality"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/jssc.200301367","volume":"26","author":"Djang\u2019eing\u2019a Marini R.","year":"2003","unstructured":"Djang\u2019eing\u2019a Marini R.; Chiap P.; Boulanger B.; Dewe W.; Hubert P.; Crommen J.; LC method for the simultaneous determination of R \u2010timolol and other closely related impurities in S \u2010timolol maleate: Optimization by use of an experimental design. J Sep Sci  2003,26(9-10),809-817","journal-title":"J Sep Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/chromsci\/bms025","volume":"50","author":"Sharma N.","year":"2012","unstructured":"Sharma N.; Rao S.S.; Reddy A.M.; A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form. J Chromatogr Sci  2012,50(9),745-755","journal-title":"J Chromatogr Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"628","DOI":"10.19843\/j.cnki.CN42-1779\/TQ.202004012","volume":"42","author":"Zhou Z.H.","year":"2020","unstructured":"Zhou Z.H.; Zuo B.; Ma X.X.; Wu L.; Synthesis and characterization of (S)-. Timolol Hemihydrate J Wuhan Univ Technol  2020,42,628-632","journal-title":"Timolol Hemihydrate J Wuhan Univ Technol"},{"key":"ref=34","first-page":"49","volume":"2","author":"Huang J.X.","year":"1999","unstructured":"Huang J.X.; Yu G.G.; Li M.X.; A new method for synthesis of (E)-6- I-3-methyl-2 -ethyl enlate Chemical notification  1999,2,49-51","journal-title":"Chemical notification"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3969\/j.issn.1672-5425.2015.03.004","volume":"32","author":"Liao F.","year":"2015","unstructured":"Liao F.; Xiao Y.; Li X.; Yu Z.Y.; Liu X.C.; progress of Synthesis of 1-Hydroxyeth oxyethyl- piperazine. ChemistryandBioengineering  2015,32(3),18-20","journal-title":"ChemistryandBioengineering"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3866\/PKU.DXHX202111018","volume":"37","author":"Sun C.B.","year":"2022","unstructured":"Sun C.B.; Zhang Z.B.; Chen Y.Z.; Kuang Y.H.; Liao X.J.; Feng P.J.; One-pot, three-step synthesis of o-Aminophenol derivatives from nitro arenes. UnivChem  2022,37(5),1-8","journal-title":"UnivChem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.14142\/j.cnki.cn21-1313\/r.2020.03.008","volume":"30","author":"Li C.","year":"2020","unstructured":"Li C.; Wang X.; Posaconazole synthetic route diagram. Chin J Chem  2020,30(3),182-186","journal-title":"Chin J Chem"},{"key":"ref=38","author":"Li Y.","year":"2013","unstructured":"Li Y.;  Study on Synthesis and Activity of New Timolol Analogues  2013","journal-title":"Study on Synthesis and Activity of New Timolol Analogues"},{"key":"ref=39","first-page":"180","volume":"17","author":"Gao G.T.","year":"2007","unstructured":"Gao G.T.; Improved synthesis of 3-(3-chloro-1\u201a2\u201a5- thiadiazol-4-yl)pyridine. Z red fruit Y aw hu A point za value  2007,17(3),180-182","journal-title":"Z red fruit Y aw hu A point za value"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.13822\/j.cnki.hxsj.2016.01.017","volume":"38","author":"Xia R.","year":"2016","unstructured":"Xia R.; Yang S.H.; Sun L.P.; Qu G.R.; New synthesis of 2-Thioadenosine. Chemical Reagents  2016,38(1),70-72","journal-title":"Chemical Reagents"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"152198","DOI":"10.1016\/j.tetlet.2020.152198","volume":"61","author":"Meguro Y.","year":"2020","unstructured":"Meguro Y.; Noguchi M.; Li G.F.; Shoda S.I.; Efficient generation of thiolate sugars from glycosyl Bunte salts and its application to S-glycoside synthesis. Tetrahedron Letters  2020,61(36),152198","journal-title":"Tetrahedron Letters"},{"key":"ref=42","first-page":"743","volume":"9","author":"Zhou Z.S.","year":"1988","unstructured":"Zhou Z.S.; Zhu J.L.; Synthesis of optically active timolol. Chem J Chin Univ  1988,9,743-745","journal-title":"Chem J Chin Univ"},{"key":"ref=43","first-page":"27","volume":"29","author":"Zhou J.H.","year":"2006","unstructured":"Zhou J.H.; Sun S.S.; Yin H.X.; Xu C.M.; Wang Y.Y.; Research of the synthesis of chiral drug S-(-)-Timolol J Jining Med Coll  2006,29(02),27-30","journal-title":"S-(-)-Timolol J Jining Med Coll"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3906\/kim-1504-65","volume":"40","author":"Saddique F.A.","year":"2016","unstructured":"Saddique F.A.; Zahoor A.F.; Yousaf M.; Irfan M.; Ahmad M.; Mansha A.; Khan Z.A.; Naqvi S.A.R.; Synthetic approaches towards the synthesis of beta-blockers (betaxolol, metoprolol, sotalol, and timolol). Turk J Chem  2016,40(2),193-224","journal-title":"Turk J Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molcatb.2007.12.003","volume":"54","author":"Kamal A.","year":"2008","unstructured":"Kamal A.; Krishnaji T.; Khan M.N.A.; Lipase-catalyzed resolution of 1-chloro-3-[(4-morpholin-4-yl-1,2,5-thiadiazole-3-yl)oxy]propan-2-ol. J Mol Catal, B Enzym  2008,54(1-2),55-59","journal-title":"J Mol Catal, B Enzym"},{"key":"ref=46","first-page":"289","volume":"4","author":"Wang D.C.","year":"1994","unstructured":"Wang D.C.; Lu W.; Zhou G.L.; Yan H.Y.; Synthesis of timolol tartrate and preliminarystudies on its lowering the intraocular pressure. Chin J Chem  1994,4(4),289-291","journal-title":"Chin J Chem"},{"key":"ref=47","first-page":"55","volume":"34","author":"Xu L.","year":"2007","unstructured":"Xu L.; He J.F.; Yang L.M.; Preparation of cellulose tris(benzoate)s and thin-layer chromatographic separation of (DL)-. Timolo Guangdong Chem Indus  2007,34(9),55-57","journal-title":"Timolo Guangdong Chem Indus"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10593-012-1032-0","volume":"48","author":"Baeva L.A.","year":"2012","unstructured":"Baeva L.A.; Biktasheva L.F.; Nikitina T.S.; Fatykhov A.A.; Lyapina N.K.; Synthesis of 1,1\u2032-{3-[(alkylsulfanyl)methyl]-tetrahydro-2H-thiopyran-3,5-diyl}diethanones from sodium sulfide and thiols. Chem Heterocycl Compd  2012,48(4),601-605","journal-title":"Chem Heterocycl Compd"},{"key":"ref=49","first-page":"80","volume":"13","author":"Li Z.F.","year":"2001","unstructured":"Li Z.F.; Luo F.Y.; synthesis and characterization of n-substituted phenyl-n\u2032-[6-(2-chlorobenzothiazol)yl]urea. Chem Res Application  2001,13(1),80-82","journal-title":"Chem Res Application"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1080\/10426507.2011.621003","volume":"187","author":"Liu Q.","year":"2012","unstructured":"Liu Q.; Hou X.M.; One-pot three-component synthesis of 3-Methyl-4-Arylmethylene- Isoxazol-5(4H)- ones catalyzed by sodium sulfide. Phosphorus Sulfur Silicon Relat Elem  2012,187(4),448-453","journal-title":"Phosphorus Sulfur Silicon Relat Elem"}],"container-title":["Current Organic Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115701794344307241027093947","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/239015\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115701794344307241027093947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T04:44:48Z","timestamp":1753245888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/239015\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115701794344307241027093947","relation":{},"ISSN":["1570-1794"],"issn-type":[{"type":"print","value":"1570-1794"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-08-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}